Allergy and Immunology, Allergy · Naples, FL
NPI
1508865924
Since 2005
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 Goodlette Rd N, Suite 200
Naples, FL, 34102
Phone (239) 434-6200
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
89,101 services
Medicare patients, 2024
1,436
Average age 76
Drug cost, 2024
$1.4M
4,786 prescriptions
Company payments, 2025
$93K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brett E Stanaland was code J2356 (injection, tezepelumab-ekko, 1 mg), 26,460 times for 15 patients. In total Brett E Stanaland billed 89,101 services in 33 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 26,460 | 15 | $14.25 | $377K |
| J2357 Injection, omalizumab, 5 mg | Office | 14,700 | 30 | $29.79 | $438K |
| J2182 Injection, mepolizumab, 1 mg | Office | 14,300 | 16 | $23.78 | $340K |
| 95004 Test - Miscellaneous | Office | 11,797 | 196 | $2.76 | $33K |
| 95165 Treatment - Miscellaneous | Office | 6,350 | 239 | $11.36 | $72K |
| 95024 Test - Miscellaneous | Office | 5,366 | 166 | $6.38 | $34K |
| 95117 Treatment - Miscellaneous | Office | 3,032 | 266 | $8.51 | $26K |
| 99213 Office E&M - Established | Office | 2,047 | 1,296 | $64.64 | $132K |
| 95115 Treatment - Miscellaneous | Office | 1,059 | 94 | $7.16 | $7,584 |
| 95044 Test - Miscellaneous | Office | 860 | 29 | $4.06 | $3,488 |
| 96401 Chemotherapy Administration | Office | 806 | 69 | $56.49 | $46K |
| 95018 Test - Miscellaneous | Office | 451 | 37 | $15.78 | $7,118 |
| 99204 Office E&M - New | Office | 296 | 296 | $115.80 | $34K |
| 94010 Pulmonary Function Testing | Office | 171 | 156 | $19.30 | $3,301 |
| 99214 Office E&M - Established | Office | 116 | 104 | $94.04 | $11K |
By year: 2022 $1.3M for 56,054 services; 2023 $1.5M for 78,098 services; 2024 $1.7M for 89,101 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brett E Stanaland prescribed most often to Medicare patients was Azelastine Hcl, with 842 prescriptions and refills. In total Brett E Stanaland wrote 4,786 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 842 | 1,562 | 423 | $32K |
| Montelukast Sodium Generic | 667 | 1,921 | 235 | $8,625 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 405 | 543 | 89 | $334K |
| Ipratropium Bromide Generic | 332 | 532 | 150 | $16K |
| Azithromycin Generic | 310 | 310 | 203 | $1,396 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 211 | 232 | 112 | $4,811 |
| Pantoprazole Sodium Generic | 194 | 531 | 77 | $2,789 |
| Fluticasone Propionate Generic | 158 | 423 | 65 | $3,943 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 149 | 149 | 112 | $1,496 |
| Breo Ellipta Fluticasone/Vilanterol | 134 | 228 | 32 | $88K |
| Levocetirizine Dihydrochloride Generic | 123 | 361 | 45 | $2,629 |
| Mupirocin Generic | 89 | 89 | 62 | $576 |
| Epinephrine Generic | 88 | 92 | 75 | $16K |
| Methylprednisolone Generic | 86 | 86 | 65 | $582 |
| Doxycycline Hyclate Generic | 72 | 72 | 59 | $867 |
Brand drugs: 1,206 claims; generic drugs: 3,580 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brett E Stanaland $93K ($93K in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $69K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 69 | $69K |
| GlaxoSmithKline, LLC. GSK | 30 | $22K |
| Incyte Corporation INCY | 2 | $1,111 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $281 |
| Genzyme Corporation SNY | 6 | $139 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $136 |
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $121 |
| CSL Behring CSL.AX | 4 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $85.01 |
| Insmed, Inc. INSM | 2 | $43.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.